创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

Advanced Search

column
Research Progress in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease
WU Ruihong, ZHANG Lei, DING Yanhua, NIU Junqi
2020, 44(3): 164-178.
Abstract PDF
Advances in Research on the Roles of Hepatic Nonparenchymal Cells in Non-alcoholic Steatohepatitis
GAO Wen, WANG Jianhua
2020, 44(3): 179-193.
Abstract PDF
Liver Fibrosis: the Most Important End-point for Phase III Clinical Trials in the Treatment of Non-alcoholic Steatohepatitis
WANG Zhonghua, DING Jia, WU Jian
2020, 44(3): 194-200.
Abstract PDF
Research Progress in Diagnosis of Non-alcoholic Steatohepatitis
LONG Jianling, XU Hui, ZENG Meng, YANG Lei, ZHENG Songbai
2020, 44(3): 201-207.
Abstract PDF
Advances in the Research on Cyclin-dependent Kinase 9 and Its Inhibitors
KAN Shaoxin, LU Na
2020, 44(3): 208-214.
Abstract PDF
Advances in Research on the Role and Mechanism of Immune Cells in Sepsis
YANG Xue, LI Zhi, ZHOU Zongzhen, YANG Yong
2020, 44(3): 215-221.
Abstract PDF
Advances in Research on SARS-CoV-2 and Relevant Drugs Clinically Used
GU Yunshuang, LI Mingfeng, SUN Jianguo
2020, 44(3): 222-231.
Abstract PDF
US FDA Preparedness and Countermeasures in Public Health Emergency
CHEN Jin, XU Ran, ZHAO Dong, DU Tao
2020, 44(3): 232-242.
Abstract PDF
An Overview of New Drugs Approved in the US, EU and Japan in January and February 2020
SUN Yousong
2020, 44(3): 243-246.
Abstract PDF